Physician

Elangovan Balakrishnan, MD

According to 2025 Medicare claims, Elangovan Balakrishnan, MD (NPI: 1407843022) practices hematology/oncology in the Columbia, MO market, with the plurality of this provider's patient population coming from Boone, MO. This provider's primary affiliated billing organization is MISSOURI CANCER ASSOCIATES LLC (NPI: 1215947338; TIN: 431763016) and primary practice location at 65201-7167. Balakrishnan is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Aledade 98 MO MSSP Enhanced (ACO ID: A4998), Aledade 93 National MSSP Enhanced (ACO ID: A5206), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Balakrishnan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,143 traditional Medicare patients, billed 311,949 HCPCS/CPT codes, and received $5,424,134 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,475 prescription claims across 398 beneficiaries totaling $3,248,738 in drug costs, led by Revlimid (Lenalidomide). DME data shows 78 claims. Open Payments data shows 53 records totaling $1,043. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,780,534 to $5,424,134. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $885,325 to $3,248,738. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,818 to $4,385.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	748	180,484	$1,780,534
2016	821	309,671	$2,992,935
2017	799	304,358	$3,594,356
2018	1,071	286,971	$3,684,269
2019	1,089	339,499	$3,961,209
2020	1,089	330,424	$4,714,432
2021	1,177	387,567	$4,946,467
2022	1,188	469,171	$5,342,083
2023	1,244	368,902	$4,683,536
2024	1,143	311,949	$5,424,134

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	239	1,956	$885,325
2016	303	2,326	$832,529
2017	323	2,622	$1,026,498
2018	327	2,646	$2,275,819
2019	321	2,390	$2,344,852
2020	316	2,602	$2,541,491
2021	358	2,719	$2,737,404
2022	366	2,485	$3,541,541
2023	378	2,585	$3,619,624
2024	398	2,475	$3,248,738

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	42	$34,254
2016	13	177	$26,350
2017	N/R	128	$14,836
2018	N/R	120	$8,323
2019	12	86	$9,595
2020	N/R	30	$2,275
2021	N/R	34	$2,535
2022	N/R	12	$641
2023	N/R	74	$6,126
2024	N/R	78	$3,717

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	361	672	$91
96413	Administration of chemotherapy into vein, 1 hour or less	226	549	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	435	749	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	379	723	$12
96372	Injection of drug or substance under skin or into muscle	208	419	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	47	1,316	$834,043
Ojjaara	Momelotinib Dihydrochloride	13	390	$343,143
Brukinsa	Zanubrutinib	19	570	$267,824
Lynparza	Olaparib	14	420	$226,341
Scemblix	Asciminib Hydrochloride	12	360	$208,811

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$2,163
E1392	Portable oxygen concentrator, rental	Y	N/R	21	$771
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$445
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$339

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,043	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Elangovan Balakrishnan, MD?

Tedicare shows public-source Medicare data for Elangovan Balakrishnan, MD (NPI 1407843022), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elangovan Balakrishnan, MD have ACO affiliation data?

Elangovan Balakrishnan, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998), Aledade 93 National MSSP Enhanced (MSSP, ACO ID A5206), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Elangovan Balakrishnan, MD?

Elangovan Balakrishnan, MD is linked to MISSOURI CANCER ASSOCIATES LLC (billing NPI 1215947338) in the available physician profile data.

Does Elangovan Balakrishnan, MD have Open Payments data?

Elangovan Balakrishnan, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.